1. Darney PD. Implantable contraception. Eur J Contracept Reprod Health Care. 2000; 5:Suppl 2. 2–11.
2. Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt HJ, et al. Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception. 2010; 82:243–249.
Article
3. Mansour D, Fraser IS, Walling M, Glenn D, Graesslin O, Egarter C, et al. Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care. 2008; 34:9–12.
Article
4. James P, Trenery J. Ultrasound localisation and removal of non-palpable Implanon implants. Aust N Z J Obstet Gynaecol. 2006; 46:225–228.
Article
5. Schnabel P, Merki-Feld GS, Malvy A, Duijkers I, Mommers E, van den Heuvel MW. Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study. Clin Drug Investig. 2012; 32:413–422.
6. Singh M, Mansour D, Richardson D. Location and removal of non-palpable Implanon® implants with the aid of ultrasound guidance. J Fam Plann Reprod Health Care. 2006; 32:153–156.
7. Shulman LP, Gabriel H. Management and localization strategies for the nonpalpable Implanon rod. Contraception. 2006; 73:325–330.
Article
8. Kim S, Seo K, Song HT, Suh JS, Yoon CS, Ryu JA, et al. Determination of optimal imaging mode for ultrasonographic detection of subdermal contraceptive rods: comparison of spatial compound, conventional, and tissue harmonic imaging methods. Korean J Radiol. 2012; 13:602–609.
Article
9. Pearson S, Stewart M, Bateson D. Implanon NXT: expert tips for best-practice insertion and removal. Aust Fam Physician. 2017; 46:104–108.
10. Choi JH, Kim HY, Lee SS, Cho S. Migration of a contraceptive subdermal device into the lung. Obstet Gynecol Sci. 2017; 60:314–317.
Article